MicroBase Technology Corp. (3184) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for MicroBase Technology Corp. (3184:TWSE), powered by AI.

Current Price
$17.70
Sector
Technology
What is the MicroBase Technology Corp. stock price forecast?

MicroBase Technology Corp. is currently trading at $17.70. View real-time AI analysis on Alpha Lenz.

What is MicroBase Technology Corp. insider trading activity?

View the latest insider trading data for MicroBase Technology Corp. on Alpha Lenz.

What is MicroBase Technology Corp.'s P/E ratio?

View MicroBase Technology Corp.'s valuation metrics on Alpha Lenz.

MicroBase Technology Corp.

TWSE · 3184
NT$17.70+0.90(+5.36%)
Ask about MicroBase Technology Corp.'s future dividend policy...
Alpha Chat Insight

MicroBase Technology Corp.'s ROE is 4.7%. Explore profitability and growth together.

Ask for details

Company Overview

MicroBase Technology Corp. is a technology company specializing in the development and manufacture of non-silicon-based microelectromechanical systems (MEMS) using proprietary LIGA technology. Founded in 1997 and headquartered in Taoyuan City, Taiwan, the company is recognized as a leader in the niche field of non-silicon MEMS, distinguished by its integration of laser microprocessing and micro-electroforming for both research and mass production. Its proprietary processes enable the creation of miniaturized devices and micron-scale components applied across industries such as electronic peripherals, medical devices, and beauty products. Within the healthcare sector, MicroBase Technology Corp. is notable for its advanced drug delivery systems. Its key products include Pocket Air, an inhalation device intended for the treatment of respiratory diseases, and PharMatrix, a micro-needle product designed for convenient home use. By focusing on innovative, patient-centric solutions and holding multiple international certifications for medical devices, the company plays a vital role in improving patient outcomes and supporting healthcare professionals in Taiwan and internationally. Overall, MicroBase Technology Corp. serves as a vital supplier of miniaturized high-precision technology, supporting a range of industries with specialized MEMS components and contributing to advancements in modern medical device development.

SectorTechnology
IndustryElectronic Components
0

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$211.70MRevenue
0.00Shares Out
0Employees

Margins

53.34%Gross
20.61%EBITDA
21.67%Operating
14.23%Pre-Tax
14.24%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

5.11%Rev 3Yr
-3.26%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
68.03%Net Inc 3Yr
N/ANet Inc 5Yr

Returns

3.99%ROA
4.69%ROE
4.04%ROIC

Financial Health

NT$221.24MCash & Cash Equivalents
NT$-99.92MNet Debt
18.42%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

MicroBase Technology Corp. (ticker: 3184) is a company listed on TWSE in the Technology sector (Electronic Components).

The current price is 17.7 with a P/E ratio of -x and P/B of -x.

ROE is 4.69% and operating margin is 21.67%. Annual revenue is $212M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
MicroBase Technology Corp. (3184) Stock Forecast 2026 $17.70 — Price, Financials & Analyst Targets | Alpha Lenz